Sueda Shozo, Izoe Yousuke, Kohno Hiroaki, Fukuda Hiroshi, Uraoka Tadao
Department of Cardiology, Saiseikai Saijo Hospital, Saijo 793-0027, Japan.
Circ J. 2005 Nov;69(11):1333-7. doi: 10.1253/circj.69.1333.
Because there are no guidelines concerning coronary spasm in Japan, the present study examined the current status of the spasm provocation test.
Questionnaires concerning the number of cases of coronary angiography, percutaneous coronary intervention, and invasive/non-invasive spasm provocation tests over 3 years (2001-2003) and the status of spasm provocation tests were sent to members of the Japanese Circulation Society in 120 cardiology hospitals in the Chugoku and Shikoku areas. Completed surveys were returned from 45 hospitals, giving a collection rate of 38%. As a spasm provocation agent, acetylcholine tests were performed in 29 hospitals, and ergonovine tests in 18 hospitals. Non-invasive spasm provocation tests were performed in only 9 hospitals (20%). In total, 5,267 patients underwent acetylcholine spasm provocation test (2,387 patients) or ergonovine spasm provocation test (2,880 patients) and vasospastic angina was diagnosed in 1,663 (2.4%) patients. Invasive spasm provocation tests were performed in 7.8% of patients with diagnostic catheterization and the spasm-positive rate was 31.6%. The difference among hospitals concerning the number of invasive spasm provocation tests was remarkable, and the angiographic spasm-positive standard and acetylcholine/ergonovine dose varied among the hospitals.
Guidelines on coronary spasm in Japan are essential to overcome the current differences between institutions.
由于日本尚无关于冠状动脉痉挛的指南,本研究调查了激发试验的现状。
向中国地区和四国地区120家心脏病医院的日本循环学会成员发送了关于3年(2001 - 2003年)内冠状动脉造影、经皮冠状动脉介入治疗以及侵入性/非侵入性激发试验病例数和激发试验情况的调查问卷。45家医院返回了完整的调查问卷,回收率为38%。作为激发剂,29家医院进行了乙酰胆碱试验,18家医院进行了麦角新碱试验。仅9家医院(20%)进行了非侵入性激发试验。共有5267例患者接受了乙酰胆碱激发试验(2387例患者)或麦角新碱激发试验(2880例患者),1663例(2.4%)患者被诊断为血管痉挛性心绞痛。在诊断性导管插入术患者中,7.8%进行了侵入性激发试验,痉挛阳性率为31.6%。各医院之间侵入性激发试验的数量差异显著,各医院的血管造影痉挛阳性标准以及乙酰胆碱/麦角新碱剂量各不相同。
日本冠状动脉痉挛指南对于克服当前各机构之间的差异至关重要。